Search | Page 4 | Aplastic Anemia and MDS International Foundation


Search results

  1. Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus-Host Disease (BMT CTN 1301)

    ... undergoing myeloablative conditioning hematopoietic stem cell transplantation. ... Exclusion Criteria:  Prior autologous or allogeneic hematopoietic stem cell transplant ...

    Clinical Trial last updated 06/06/2016 - 1:36pm.

  2. Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

    ... immediately Research participants must have a donor or stem cell source identified for allogeneic transplantation, either related (7/8 ... CD123-CAR/CD28-costimulatory, lentiviral vector-transduced autologous T lymphocytes Given IV Other Name: CD123R(EQ)28zeta/EGFRt+ ...

    Clinical Trial last updated 07/14/2016 - 4:08pm.

  3. Intra-Osseous Co-Transplant of UCB and hMSC

    ... the patient's immune system from rejecting the donor's stem cells . The donated stem cells may replace the patient's immune cells ... (myeloid sarcoma or chloroma) Recipients of prior autologous or allogeneic transplant are eligible, as long as at least 3 months ...

    Clinical Trial last updated 05/02/2016 - 11:15am.